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Abstract
The natural flavone acacetin has been demonstrated to inhibit transient outward potassium current (Ito) in human atrial
myocytes. However, the molecular determinants of acacetin for blocking Ito are unknown. The present study was designed
to investigate the properties and molecular determinants of this compound for blocking hKv4.3 channels (coding Ito) stably
expressed in HEK 293 cells using the approaches of whole-cell patch voltage-clamp technique and mutagenesis. It was
found that acacetin inhibited hKv4.3 current by binding to both the closed and open channels, and decreased the recovery
from inactivation. The blockade of hKv4.3 channels by acacetin was use- and frequency-dependent, and IC50s of acacetin for
inhibiting hKv4.3 were 7.9, 6.1, 3.9, and 3.2 mM, respectively, at 0.2, 0.5, 1, and 3.3 Hz. The mutagenesis study revealed that
the hKv4.3 mutants T366A and T367A in the P-loop helix, and V392A, I395A and V399A in the S6-segment had a reduced
channel blocking efficacy of acacetin (IC50, 44.5 mM for T366A, 25.8 mM for T367A, 17.6 mM for V392A, 16.2 mM for I395A, and
19.1 mM for V399A). These results demonstrate the novel information that acacetin may inhibit the closed channels and
block the open state of the channels by binding to their P-loop filter helix and S6 domain. The use- and rate-dependent
blocking of hKv4.3 by acacetin is likely beneficial for managing atrial fibrillation.
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Introduction
It is well recognized that the 4-aminopyridine- (4-AP-) sensitive
transient outward potassium current Ito is expressed in cardiomy-
ocytes from mouse [1,2], rat [3], rabbit [4], ferret [5], cat [6],
canine [7], and human [8], but not in cardiomyocytes from guinea
pig [9] and pig hearts [10,11]. Ito is heterogeneously expressed in
transmural ventricular wall of the hearts in human and dogs,
determines the morphologies of cardiac action potentials, and
generates the prominent phase 1 repolarization and ‘‘spike and
dome’’ profile of ventricular epicardial and midmyocardial
myocytes in these species [7,12]. In human and canine hearts,
Ito is principally encoded by Kv4.3 (KCND3) gene [13,14]. Recent
studies have demonstrated that Brugada syndrome-associated Ito
gain-of-function mutations in KCND3-encoded Kv4.3 is believed
to mediate an alteration of transmural voltage gradient (epicar-
dium . endocardium), and result in a net outward shift in current
and heterogeneous loss of the action potential dome, ST segment
elevation on electrocardiogram (ECG), and the development of
potentially fatal polymorphic ventricular tachycardia or ventricu-
lar fibrillation via phase II reentry [15].
Our previous study [16] has demonstrated the natural flavone
acacetin, in addition to blocking human atrial ultra-rapidly-
delayed rectifier potassium current (IKur) and acetylcholine-
activated potassium current (IK.ACh), effectively inhibits human
atrial Ito. This compound increased the atrial effective refractory
period and prevented the occurrence of atrial fibrillation in
anesthetized dogs without prolonging the QT interval [16]. Our
recent study has shown that the natural flavone acacetin is an open
channel blocker of hKv1.5 channels with use- and frequency-
dependent blocking properties by binding to the S6 domain of the
channels [17]. The present study was designed to investigate the
properties and molecular determinants of acacetin for inhibiting
hKv4.3 channels with whole-cell patch voltage-clamp and
mutagenesis approaches.
Materials and Methods
Cell line culture and gene transfection
The HEK 293 cell line [18] stably expressing the human Kv4.3
(KCND3) gene kindly provided by Dr. Klaus Steinmeyer (Sanofi-
Aventis Deutschland GmbH) was maintained in Dulbecco’s
modified eagle’s medium (DMEM, Invitrogen, Hong Kong)
supplemented with 10% fetal bovine serum and 400 mg/mL
G418 (Sigma–Aldrich). Cells used for electrophysiology recording
were seeded on a glass cover slip.
Polymerase chain reaction-based site-directed mutagenesis was
used to produce mutations of the pCDNA3.1/hKv4.3 plasmid.
Primers used to generate the channel mutants were synthesized by
the Genome Research Center, the University of Hong Kong
(Hong Kong), and the mutants were generated using a
QuikChange kit (Stratagene, La Jolla, CA), and confirmed by
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DNA sequencing. The mutant was transiently expressed with 4 mg
of hKv4.3 mutant cDNA plasmid using 10 ml of Lipofectamine
2000 to determine the mutant hKv4.3 currents.
Drugs and solutions
Acacetin synthesized in the laboratory as described previously in
the US patent (http://www.patentstorm.us/patents/7816400.
html) [19] was used in the present study. The compound was
dissolved in dimethyl sulfoxide (DMSO) as a 100 mM stock
solution. Aliquot stock was stored at –20uC. Tyrode’s solution
contained (in mM) 140 NaCl, 5.4 KCl, 1 MgCl2, 1 CaCl2, 10
HEPES, 10 glucose; pH was adjusted to 7.3 with NaOH. The
pipette solution contained (in mM) 20 KCl, 110 K-aspartate, 1
MgCl2, 10 HEPES, 5 EGTA, 0.1 GTP, 5 Na-phosphocreatine,
and 5 Mg-ATP; pH was adjusted to 7.2 with KOH.
Patch-clamp recording
The coverslips with adherent HEK-hKv4.3 cells on the surface
were transferred to an open cell chamber mounted on the stage of
an inverted microscope and superfused at 2–3 mL/min. The
whole-cell patch-clamp technique was used for electrophysiolog-
ical recording as described previously [17,18]. Borosilicate glass
electrodes (1.2-mm OD) were pulled using a Brown-Flaming
puller (model P-97, Sutter Instrument Co, Novato, CA, USA).
They had tip resistances of 2–3 MV when filled with the pipette
solution. Membrane currents were recorded in voltage-clamp
mode using an EPC 10 amplifier and Pulse software (HEKA,
Lambrecht, Germany). A 3-M KCl-agar salt bridge was used as
the reference electrode. The tip potential was zeroed before the
patch pipette touched the cell. After a gigaohm seal was obtained,
the cell membrane was ruptured by gentle suction to establish the
whole-cell configuration. The series resistance (Rs) was 3–5 MV
and was compensated by 50–70% to minimize voltage errors, and
membrane capacitance was electrically compensated. Liquid
junction potential (15.7 mV, calculated with Clampex 9.2)
between pipette solution and bath solution was not adjusted
during the experiments. Current signal was sampled at 10 kHz,
recorded and stored in the hard disk of an IBM compatible
computer. The experiments were conducted at room temperature
(22–23uC).
Data analysis
The results are expressed as mean6SEM. Non-linear curve
fitting was performed with Pulsefit (HEKA) and Sigmaplot 10.0
(SPSS, Chicago, Ill). Statistical comparisons were analyzed by
Student’s t test for two group data or one-way ANOVA followed
by Tukey’s test was used for multiple groups. P values less than
0.05 were considered to indicate statistically significant differences.
Results
Inhibition of hKv4.3 current by acacetin
Figure 1A illustrates the time course of hKv4.3 current recorded
in a representative cell, in the absence and presence of 10 mM
acacetin, using a 300-ms voltage step to +50 mV from a holding
potential of 280 mV (inset, 0.2 Hz). Acacetin gradually inhibited
the hKv4.3 current. The current amplitude was measured from
zero to the current peak. The inhibitory effect significantly
recovered on washout. Similar results were obtained in eight other
cells.
Figure 1B displays the voltage-dependent hKv4.3 current
determined in a typical experiment with the voltage protocol
shown in the inset, in the absence and presence of acacetin. The
current was inhibited by 3, 10, or 30 mM acacetin in a
concentration-dependent manner. Figure 1C shows the current-
voltage (I–V) relationships of hKv4.3 current during control and
after application of 3, 10, and 30 mM acacetin. The current was
significantly inhibited by acacetin (n = 15, P,0.05 or P,0.01 vs.
control at 0 to +60 mV).
To analyze the blocking properties of hKv4.3 channels, a 300-
ms voltage step to +50 mV from a holding potential of 280 mV
was used to record the current before acacetin application (10-s
interval), and then discontinued during six min of 10 mM acacetin
administration (Fig. 2A) at a holding potential 280 mV to ensure
that all channels were in the closed state. The blocking effect of
hKv4.3 channels by acacetin was evaluated by reapplying the
protocol after the six min of exposure. Remarkable suppression of
Figure 1. Inhibition of hKv4.3 current by acacetin. A. Time course
of hKv4.3 step current recorded in a representative HEK 293 cell stably
expressing KCND3 gene in the absence and presence of 10 mM acacetin
with a 300-ms test pulse from –80 to +50 mV (inset). Original current
traces at corresponding time points are shown in the right of the panel.
B. Voltage-dependent hKv4.3 current traces recorded in another cell
using the protocol as shown in the inset in the absence (control) and
presence of 3, 10, and 30 mM acacetin (8 min for each concentration). C.
Current-voltage (I–V) relationships of hKv4.3 current in the absence and
presence of 3, 10 and 30 mM acacetin (n = 12, P,0.05 or P,0.01 vs.
control at 210 to +60 mV).
doi:10.1371/journal.pone.0057864.g001
Acacetin Blocks hKv4.3 Channels
PLOS ONE | www.plosone.org 2 March 2013 | Volume 8 | Issue 3 | e57864
hKv4.3 current by acacetin was observed at 1st pulse of the
reapplied voltage step (Fig. 1A). No significant difference was
observed between the current recorded at 1st pulse and those
recorded by the following pulses. The channel blockade was
reversed by drug washout. Similar results were obtained in other
four cells.
It should be noted that inhibitory effect of acacetin on hKv1.5
current increases at following pulses after the 1st pulse of reapplied
voltage step by binding to the open channels [17]. No difference
for the inhibiting effect on the 1st pulse-hKv4.3 current and the
currents activated by following pulses suggests that acacetin might
inhibit the closed channels. However, it is generally believed that
the closed channel blocker 4-aminopyridine slowed the inactiva-
tion process and decreased the time to peak current in Kv4.2
channel current expressed in Xenopus oocytes and transient
outward potassium current (Ito) in ferret cardiac myocytes, and
induced a ‘crossover phenomena’ of the current [5,20]. However,
acacetin clearly facilitated hKv4.3 current inactivation (Fig. 1A
and 1B), reduced the time to peak current, and also induced a
strong inhibition of steady-state (or sustained) current (ISS) (right
panel of Fig 2A). This suggests that acacetin likely inhibit the
current by binding to both the closed and open channels.
To analyze the open channel blocking property, hKv4.3 traces
were expanded to measure the time to peak of hKv4.3 channel
Figure 2. Blocking properties of hKv4.3 channels by acacetin. A. Time course of hKv4.3 current recorded in a representative cell with the
voltage step shown in the inset during control and after 10 mM acacetin superfusion for 6 min without the voltage pulse depolarization and for 2 min
with the voltage pulse depolarization, then drug washout. The currents recorded at corresponding time points are shown in the right of the panel.
The arrows indicate the time to peak of the current activation. Itotal, total current; ISS, steady-state (or sustained) current. B. Expanded current traces of
hKv4.3, showing the measurement of the time to peak of hKv4.3 current. C. Mean values of the time to peak of the current activation at 0 to +60 mV
before and after application of 3 and 10 mM acacetin (n = 10 experiments, P,0.01 vs. control). D. Inactivation of hKv4.3 current was fitted to a
monoexponetial equation with the time constants shown before (control) and after 10 mM acacetin. E. Mean values of time constant of hKv4.3
current inactivation at 0 to +60 mV before and after application of 3 and 10 mM acacetin (n = 10 experiments, P,0.01 vs. control).
doi:10.1371/journal.pone.0057864.g002
Acacetin Blocks hKv4.3 Channels
PLOS ONE | www.plosone.org 3 March 2013 | Volume 8 | Issue 3 | e57864
activation before and after application of 10 mM acacetin (Fig. 2B).
The mean values of the voltage-dependent time to peak of the
channel were significantly reduced by 3 or 10 mM acacetin at all
test potentials (Fig. 2C). Figure 2D shows that hKv4.3 current was
well-fitted to a monoexponential function with the time constants
shown before and after 10 mM acacetin. The inactivation time
constant of Kv4.3 current was significantly reduced by 3 or 10 mM
acacetin at all test potentials (0 to +60 mV, n= 10, P,0.01 vs.
control). These results support the notion that acacetin also
inhibits hKv4.3 current by blocking the open channel.
Effects of acacetin on kinetics of hKv4.3 current
Figure 3A shows the representative current and voltage protocol
used for determining the availability (I/Imax) of hKv4.3 current.
Figure 3B illustrates the tail current recorded by the voltage
protocol for determining the steady-state activation (g/gmax) of the
channel. The variables (Fig. 3C) of I/Imax and g/gmax were fitted
to a Boltzmann function in individual cells as described previously
[12]. The V1/2 of hKv4.3 current availability was not significantly
changed (231.361.7 mV in control, and 235.761.1 mV in
10 mM acacetin, n = 8, P=NS vs. control), while the V1/2 of
activation conductance was positively shifted by 10.1 mV
(21.761.8 mV in control, 8.462.9 mV in acacetin, n= 9,
P,0.01 vs. control). This effect was not observed in human atrial
Ito [16], and this difference may be related to the lack of the
regulatory b-subunits KChIPs in HEK 293 cells.
The effect of acacetin on the recovery kinetics of hKv4.3 current
was determined with a paired pulse using a 300-ms step to
+50 mV from a holding potential of280 mV with variable P1–P2
interval as shown in the inset of Fig. 4A. Acacetin (10 mM) reduced
the current amplitude and slowed the recovery of hKv4.3 current
from inactivation. The recovery time course was fitted to a
monoexponential function in individual cells before and after
application of 10 mM (Fig. 4B). The time constant (t) of recovery
from inactivation of hKv4.3 current was increased from
112.7613.6 ms in control to 188.2619.5 ms after 10 mM acacetin
(n = 9, P,0.01 vs. control). The slowed recovery of hKv4.3
current from inactivation was similar to the observation in human
atrial Ito [16].
Use- and frequency-dependent block of hKv4.3 channels
by acacetin
The slowed recovery of hKv4.3 channels from inactivation
suggests that blockade of hKv4.3 channels may be use- and
frequency-dependent. The use-dependent blockade of hKv4.3
channels by acacetin was determined at 0.2, 1, 2, and 3.3 Hz using
a train of 20 pulses of a 200-ms voltage step. Figure 5A shows the
normalized hKv4.3 current traces recorded at 3.3 Hz in a
representative cell before and after application of 3 mM acacetin.
Though hKv4.3 current showed a significant use-dependent
inhibition in control, the use-dependent blockade was evident
with acacetin. The current blockade at the first pulse was less than
that at following pulses. The fractional blockade of hKv4.3 current
at each frequency with 3 mM acacetin is illustrated in Fig. 5B. The
use-dependent blockade was enhanced as the depolarization
frequency was increased. In addition, acacetin exhibited more
potent of inhibition on hKv4.3 current at 3.3 Hz than that at
0.2 Hz and 1.0 Hz. Figure 5C shows the percentage current at the
20th pulse of different frequencies with 0.1–100 mM acacetin. The
curves were fitted to a Hill equation to obtain the IC50. The IC50
of acacetin for inhibiting hKv4.3 current was reduced as increase
of the depolarization frequency (IC50: 7.9, 6.1, 3.9, and 3.2 mM at
0.2, 1.0, 2.0, and 3.3 Hz, respectively).
Effect of acacetin on closed-state inactivation of hKv4.3
current
The steady-state inactivation of Kv4.3 channels occurs
predominantly from the closed state [21,22], here we determined
whether acacetin would affect the development kinetics of closed-
state inactivation of hKv4.3 channels. Acacetin (10 mM) slightly
accelerated the closed-state inactivation of hKv4.3 channels
(Figure S1). The closed-state inactivation time constant was
1683.36134.1 ms in control, and 1355.2659.2 ms in 10 mM
acacetin (n = 6, P,0.05 vs. control). The result suggests that
acacetin may accelerate the kinetics of closed-state inactivation of
hKv4.3 channels.
Molecular determinants of hKv4.3 channel blockade by
acacetin
The molecular determinants of the blockade of hKv4.3
channels by acacetin were investigated using the mutants T366A
and T367A in the P-loop helix, and V392A, I395A, and V399A in
the S6 transmembrane domain. Figure 6A shows the representa-
tive current traces of wild type (WT), T366A, T367A, V392A,
I395A, and V399A hKv4.3 channels activated with a 300-ms
voltage step to +50 mV from a holding potential of 280 mV in
Figure 3. Effects of acacetin on voltage-dependent kinetics of
hKv4.3 current. A. Protocol and current traces used to assess
availability (I/Imax, steady-state inactivation) of hKv4.3 current. B.
Protocol and tail current traces used to assess activation conductance
(g/gmax, steady-state activation) of hKv4.3 current. C. Mean values of
hKv4.3 current (I/Imax) variables and conductance (g/gmax) variables
before and after 10 mM acacetin were fitted to the Boltzmann function:
g = 1/(1+exp((V1/22Vt)/K)), where V1/2 is the voltage of 50% channel
availability or maximal activation of the channel, Vt is the test potential,
and K is slope factor.
doi:10.1371/journal.pone.0057864.g003
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the absence and presence of acacetin (30 mM). Acacetin at 30 mM
markedly blocked the WT hKv4.3 current. Less inhibition was
observed for the T366A, T367A, V392A, I395A, and V399A
currents. The mean values of percentage inhibition of hKv4.3
currents are illustrated in Fig. 7B. Acacetin at 30 mM inhibited the
WT hKv4.3 current by 74.263.3% (n= 12), T366A by
49.168.3% (n= 8, P,0.01 vs. WT), T367A by 54.966.5%
(n= 7, P,0.01 vs. WT), V392A by 64.563.9% (n= 9, P,0.05 vs.
WT), I395A by 65.662.7% (n= 8, P,0.05 vs. WT), and V399A
by 62.963.7% (n= 6, P,0.05. vs. WT), respectively.
The concentration-dependent response to acacetin was evalu-
ated in WT and mutant hKv4.3 channels, and the resulting curves
were fitted to a Hill equation as in Fig. 7A. The IC50s (at 0.2 Hz)
of acacetin in inhibiting hKv4.3 currents were 7.9 mM for WT,
44.5 mM for T366, 25.8 mM for T367A, 17.6 mM for V392A,
16.2 mM for I395A, and 19.1 mM for V399A, respectively. These
results suggest that T366 and T367 in the P-loop helix, V392,
I395, and V399 in the S-6 segment are the molecular determi-
nants of channel blocking by acacetin (Fig. 7B).
Discussion
The present study demonstrates that the natural flavone
acacetin inhibits hKv4.3 channels stably expressed in HEK 293
cells in a use- and frequency-dependent manner by binding to not
only the open state of the channels, but also the closed channels.
The effect of acacetin for blocking hKv4.3 current was enhanced
as the stimulus frequency was increased from 0.2 Hz
(IC50 = 7.9 mM) to 3.3 Hz (IC50 = 3.2 mM). The efficacy at
0.2 Hz is close to that for inhibiting human atrial Ito
(IC50 = 9.3 mM) [16].
In addition to the use- and frequency-dependent effect, the open
channel blocking property of acacetin was reflected in the reduced
time to peak of the current activation and the decreased time
constant of Kv4.3 current inactivation. This indicates that acacetin
Figure 4. Effect of acacetin on recovery of hKv4.3 current from
inactivation. A. Protocol and hKv4.3 current traces recorded in a
representative cell before (control) and after 10 mM acacetin (8 min)
used to assess the time constant of recovery of the channel from
inactivation. B. Mean values of recovery time course of hKv4.3 current
from inactivation were fitted to a mono-exponential function before
and after application of 10 mM acacetin.
doi:10.1371/journal.pone.0057864.g004 Figure 5. Use- and frequency-dependent inhibition of hKv4.3
current by acacetin. A. hKv4.3 current traces recorded in a
representative cell with a 200-ms pulse at 3.3 Hz before (control) and
after application 3 mM acacetin. B. Mean percentage values of use-
dependent inhibition of hKv4.3 current (at +50 mV) by 3 mM acacetin at
0.2, 1, 2, and 3.3 Hz. C. Concentration-response relationship curves of
acacetin for inhibiting hKv4.3 current at 20th pulse were fitted to Hill
equation to obtain IC50 (n = 7–15 experiments for each concentration or
frequency) at frequencies of 0.2–3.3 Hz.
doi:10.1371/journal.pone.0057864.g005
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may quickly bind to the channels when they open. The open
channel property of acacetin is further supported by the slowed
recovery of hKv4.3 channels from inactivation and the positive
shift of g/gmax of the channel activation. This is different from the
Kv4.3 blocker allitridi that also binds to the open state of the
channel, but does not show a slowed recovery from inactivation
and use- and frequency-dependent effect [23], which may be
related to that acacetin is not a pure open channel blocker for
hKv4.3 channels. Acacetin also inhibits the closed channels, which
is reflected in the remarkable suppression of the current activated
by the 1st pulse of reapplied voltage steps after administration of
acacetin. This property is different from that in blocking open
channels of hKv1.5 [17]. The blockade of hKv4.3 and hKv1.5
channels by acacetin is likely from cytoplasmic surface, because
both hKv4.3 current and hKv1.5 current were not significantly
inhibited by intracellular dialysis with the patch pipette solution
containing 10 mM acacetin (the authors’ unpublished observa-
tions). Therefore, the intrinsic inactivation gating (i.e. ball and
chain) of hKv4.3 channels may not be affected by acacetin. In
addition, acacetin slightly accelerated the closed-state inactivation
of the channel. These are illustrated in the blocking scheme (Fig. 8).
Mutagenesis experiments revealed that the inhibitory efficacy of
acacetin on the hKv4.3 mutants T366A and T367A of the P-loop
of the pore helix was significantly reduced. This implies that
acacetin may be trapped into the channel pore and block the open
channel. Moreover, the mutants V392A, I395A, and also V399A,
of the S6 domain exhibit a significantly reduced response to
acacetin, indicating that in addition to binding to the P-helix filter,
acacetin may interact with V392, I395, and V399 of the S6
domain. Therefore, the five residues T366, T367, V392, I395, and
V399 of the channel are involved in the inhibition of hKv4.3
current by acacetin. These sites are the equivalent residues of
T479, T480, V505, I508, and V512 of hKv1.5 channels,
respectively [17]. However, the blocking binding sites of acacetin
for blocking Kv4.3 channels are slightly different from those for
blocking Kv1.5 channels where the P-loop helix (e.g. T480) is not
involved in the binding of acacetin [17].
It is generally believed that Ito is relatively larger in the atrial
cells than that in the ventricular cells, so that inhibition of Ito may
cause a prolongation of repolarization predominantly in the atria
more than that in the ventricle [24]. Human cardiac Ito (or Kv4.3)
is considered to be a target for developing anti-atrial fibrillation
Figure 6. Effects of acacetin on WT and mutant hKv4.3
currents. A. Current traces recorded in HEK 293 cells expressing WT,
T366A, T367A, V392A, I395A, and V399A hKv4.3 channels, respectively,
with a 300-ms voltage step to +50 mV from a holding potential of
280 mV before (control) and after 30 mM acacetin treatment for 5 min.
The arrows indicate the current inhibition levels. B. Mean percent
inhibition of WT and mutant hKv4.3 currents by 30 mM acacetin (n = 12
for control, n = 5–7 for each mutant; *P,0.05, **P,0.01 vs. WT).
doi:10.1371/journal.pone.0057864.g006
Figure 7. Molecular determinants of hKv4.3 channel block by
acacetin. A. Concentration-response relationship curves were fitted to
the Hill equation to obtain the IC50s of acacetin for inhibiting WT and
mutant hKv4.3 channels as shown in the inset (n = 5–12 for each
concentration). B. Schematic graph showing the putative binding sites
of acacetin at T366, T367 in the P-loop helix and V392, I395, and V399 in
the S6-segment of Kv4.3 channels.
doi:10.1371/journal.pone.0057864.g007
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drugs [24,25]. Acacetin inhibited hKv4.3 current, especially at
high frequencies. Although the blockade of hKv4.3 channels by
acacetin is relatively weaker than that of hKv1.5 channels, the
combination with its frequency-dependent blockade of hKv1.5/
IKur [17], favors the prolongation of atrial action potential
duration and/or effective refractory period in human atrial
myocytes, which benefits for anti-atrial fibrillation. This effect
has been observed in experimental canine model [16].
An increase of Ito has been found to be involved in genesis of
cardiac ventricular arrhythmias or Brugada syndrome [15,26–28].
Because Ito plays a crucial role in phase 1 fast repolarization of
ventricular action potentials, especially in the midmyocardium and
epicardium in humans [8,12,29] and in dogs [7]. Up-regulation of
Ito is involved in generation of Brugada syndrome and idiopathic
ventricular fibrillation [30] by shifting cardiac repolarization and
inducing J-wave syndromes that triggers the life-threatening
arrhythmia [15,31]. It has been documented that an increase of
Ito amplitude by gain-of-function mutations in the KCND3-
encoded Kv4.3 channels is the molecular pathogenesis for the
lethal arrhythmia in patients with Brugada syndrome [30].
Suppression of ventricular arrhythmia in Brugada patients with
quinidine [32,33] is believed to be related to its Ito blocking effect
[34–36].
A recent study has reported that oxidation stress increases Ito
conductance and promotes EADs (early after-depolarizations) by
setting myocardial action potential plateau into the voltage range
where ICa,L reactivation is facilitated and IKs activation is slowed,
and the EADs are suppressed by the Ito blocker 4-AP [28]. It
should be noted that Ito inhibition by 4-AP may restore the
epicardial action potential dome, reduce both transmural and
epicardial dispersion of repolarization, normalize the ST segment,
and prevent phase 2 reentry and ventricular tachycardia/
ventricular fibrillation in experimental Brugada syndrome
[15,31,37]. These studies suggest that Ito blockade also has a
therapeutic effect on ventricular arrhythmias resulted from
oxidation-induced EADs or Brugada syndrome. Acacetin has a
strong inhibition of hKv4.3 current, and may also be a candidate
drug in suppressing ventricular arrhythmias related to Brugada
syndrome. Although acacetin also blocks hKv1.5 channels, this
effect would not affect other phases of action potential in human
ventricles, because no functional hKv1.5/IKur is present in
ventricular myocytes of human hearts [38]. Blockade of hKv4.3
by acacetin would favor the correction of Brugada’s abnormal
repolarization at early phase (phase 1) action potential in human
ventricles; however, this remains further investigation in the
future.
Collectively, the present study demonstrates that acacetin
mainly blocks hKv4.3 channels by binding to open states and
interacting with T366 and T367 in the P-loop helix and V392,
I395, and V399 within the S6 domain. The use- and frequency-
dependent blocking property of the hKv4.3 channels and also
hKv1.5 channels suggest that this natural flavone compound could
strongly inhibit atrial fibrillation. Further effort is required to study
whether it is effective in managing ventricular arrhythmias related
to Brugada Syndrome.
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